Kazuki Sudo

17PUBLICATIONS
128CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 26, 2026
Dose intensity and clinical outcomes across age groups in high-grade osteosarcoma treated with methotrexate, adriamycin, and cisplatin therapy.

|Jul 01, 2026
De-escalation of breast surgery for early stage breast cancer.

|May 16, 2026
Primary tumour resection reduces the risk of major local morbidity in de novo stage IV breast cancer: secondary data analysis from the JCOG1017 randomized clinical trial.

|Jan 30, 2026
A randomized controlled trial of metastasis-directed therapy for oligometastases in breast cancer: OLIGAMI trial (JCOG2110).

Keita Sasaki, Toshiyuki Ishiba, Ikuno Nishibuchi

|Feb 11, 2025
Germline Pathogenic Variants and Clinical Outcomes in Asian Patients With Breast Cancer.

Rui Kitadai, Shu Yazaki, Aya Kuchiba

|Aug 14, 2024
Clinicopathological and prognostic features of HER2-null and HER2-low advanced breast cancer treated with eribulin or capecitabine.

Rui Kitadai, Tatsunori Shimoi, Shu Yazaki

Pageof 3

Frequent Collaborators

11 joint publications

Kan Yonemori

7 joint publications

Takafumi Koyama

7 joint publications

Noboru Yamamoto

5 joint publications

Tatsunori Shimoi